Quince Therapeutics, Inc. (QNCX)
NGS · Common · CUSIP 22053A107
Last Price•••.••
Current Yield•.••%
Yield to Call•.••%
Yield to Worst•.••%
Free registration unlocks the quote, yield calculations, price chart and full fundamentals for QNCX and every other security on QuantumOnline.
🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

Security Profile

Security Type
Common Stock
CUSIP
22053A107
Market Cap
Micro Cap
IPO
5/9/2019 · $17.00/share
Previous Symbol
CRTX (changed 7/29/2022)
Previous Name
Cortexyme, Inc.
Business: Cortexyme, Inc. is a biotechnology company focused on acquiring, developing, and commercializing innovative therapeutics that transform the lives of patients suffering from debilitating and rare diseases.

Company Contact

CEO
Dirk Thye
CFO
Brendan Hannah
Headquarters
611 Gateway Boulevard, Suite 273, South San Francisco, CA 94080
Phone
415-910-5717
Investor Relations
Stacy Roughan · 415-910-5717 · ir@quincetx.com
Email Form
Contact Form »
SEC EDGAR Filings
View filings »